In conclusion, the molecular basis of the action of Semax and ACTH(6–9)PGP peptides includes the compensation of rat brain gene expression profiles disrupted by ischemia, as well as the influence on the genes of the growth, angiogenesis, and neurogenesis systems a day after experimental stroke. This evidence concerns the gene POMC and stroke disorder.